Woodside, CA, United States of America

Mary Lynn Moran

USPTO Granted Patents = 14 

Average Co-Inventor Count = 3.0

ph-index = 13

Forward Citations = 792(Granted Patents)


Company Filing History:


Years Active: 2009-2022

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations by Mary Lynn Moran

Introduction

Mary Lynn Moran is a prominent inventor based in Woodside, CA (US). She has made significant contributions to the field of medical technology, particularly in the treatment of sinusitis. With a total of 14 patents to her name, her work has had a substantial impact on healthcare.

Latest Patents

One of her latest patents focuses on the sinus delivery of sustained release therapeutics. This invention provides biodegradable implants designed for treating sinusitis. The biodegradable implants are engineered with specific size, shape, density, viscosity, and mucoadhesiveness to ensure they are not substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. These implants include sustained release therapeutics, such as antibiotics and steroidal anti-inflammatory agents. They can take various forms, including rods, pellets, beads, strips, or microparticles, and can be delivered into a sinus using various pharmaceutically acceptable carriers.

Career Highlights

Throughout her career, Mary Lynn Moran has worked with notable companies, including Intersect ENT GmbH and Sinexus, Inc. Her innovative approaches have led to advancements in medical treatments and have garnered attention in the industry.

Collaborations

Some of her notable coworkers include Donald J. Eaton and Rodney A. Brenneman. Their collaborative efforts have contributed to the success of her inventions and the development of new technologies.

Conclusion

Mary Lynn Moran's contributions to the field of medical technology, particularly through her innovative patents, have made a significant impact on the treatment of sinusitis. Her work continues to inspire advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…